Comparison of Blood Pressure Measurements Between Transdermal Optical Imaging and Standard of Care
1 other identifier
observational
15,000
2 countries
3
Brief Summary
Participants (patients and volunteers) will be recruited to have their blood pressure measured by standard blood pressure assessment methods while having their face video recorded. The data collected will help improve the blood pressure measurement accuracy of Transdermal Optical Imaging, which relies on machine learning to extract physiological information from videos recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2020
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 25, 2020
CompletedFirst Submitted
Initial submission to the registry
September 1, 2020
CompletedFirst Posted
Study publicly available on registry
September 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedSeptember 7, 2020
September 1, 2020
11 months
September 1, 2020
September 1, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Blood Pressure Results
Comparison of Transdermal Optical Imaging data and Standard assessment data
Single visit; up to one day
Study Arms (2)
Healthy Controls
Blood pressure measurements by standard assessment methods and Transdermal Optical Imaging
Patients
Blood pressure measurements by standard assessment methods and Transdermal Optical Imaging
Interventions
Blood pressure measurements completed by standard assessment methods and Transdermal Optical Imaging
Eligibility Criteria
Only individuals, of any sex, over the age of 13 will be included in the study.
You may qualify if:
- Able and willing to provide written informed consent to participate (including by parent or legal guardian if under 16 years old).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
University of Toronto
Toronto, Ontario, M5S 1A1, Canada
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
The Affiliated Hospital of Hangzhou Normal University
Hangzhou, Zhejiang, China
Study Officials
- PRINCIPAL INVESTIGATOR
Kang Lee, PhD
University of Toronto
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 1, 2020
First Posted
September 7, 2020
Study Start
August 25, 2020
Primary Completion
August 1, 2021
Study Completion
August 1, 2021
Last Updated
September 7, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share
No IPD will be shared with other researchers outside the team of researchers involved in the current study. Findings of the study based on group results will be shared in publications.